(Q43679493)

25 November 2017

title

Factors related to biopsy willingness in patients with advanced cancer in a phase 1 clinic for molecularly targeted therapy (English)

1 reference

25 November 2017

10

Razelle Kurzrock

1 reference

25 November 2017

David S Hong

1

1 reference

25 November 2017

Goldy C George

2

1 reference

25 November 2017

Eucharia C Iwuanyanwu

3

1 reference

25 November 2017

Bahareh Tavana

4

1 reference

25 November 2017

Gerald S Falchook

5

1 reference

25 November 2017

Sarina A Piha-Paul

6

1 reference

25 November 2017

Jennifer J Wheler

7

1 reference

25 November 2017

Reena H Mistry

8

1 reference

25 November 2017

Xiudong Lei

9

1 reference

25 November 2017

publication date

2 March 2013

1 reference

Journal of Cancer Research and Clinical Oncology

25 November 2017

published in

1 reference

25 November 2017

volume

139

1 reference

25 November 2017

issue

6

1 reference

25 November 2017

page(s)

963-970

1 reference

Impact and perceptions of mandatory tumor biopsies for correlative studies in clinical trials of novel anticancer agents

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1404-6

Estimating prognosis and palliation based on tumour marker CA 19-9 and quality of life indicators in patients with advanced pancreatic cancer receiving chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1404-6

New Results Will Change the Paradigm for Phase I Trials and Drug Approval

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1404-6

Comparison of health-related quality of life 5 years after SPIRIT: Surgical Prostatectomy Versus Interstitial Radiation Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1404-6

Outcomes of research biopsies in phase I clinical trials: the MD anderson cancer center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1404-6

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1404-6

Colon cancer patient information seeking and the adoption of targeted therapy for on-label and off-label indications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1404-6

A phase 2 trial of dasatinib in advanced melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1404-6

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1404-6

Clinical trial awareness among racial/ethnic minorities in HINTS 2007: sociodemographic, attitudinal, and knowledge correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1404-6

Preferences for active and aggressive intervention among patients with advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1404-6

Prevalence of complementary medicine use in a phase 1 clinical trials program: the MD Anderson Cancer Center Experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1404-6

Rationale for biomarkers and surrogate end points in mechanism-driven oncology drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1404-6

Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1404-6

Effects of music therapy on pain and anxiety in patients undergoing bone marrow biopsy and aspiration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1404-6

Quality of Life in Hormone Receptor–Positive HER-2+ Metastatic Breast Cancer Patients During Treatment with Letrozole Alone or in Combination with Lapatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1404-6

Phase II study of dasatinib in patients with metastatic castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1404-6

Are we taking without giving in return? The ethics of research-related biopsies and the benefits of clinical trial participation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1404-6

Gemcitabine-induced thrombotic microangiopathy: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1404-6

Characterization of metastatic breast cancer patients with nondetectable circulating tumor cells

21 January 2018

1 reference

12 December 2020

Awareness of genetic testing for breast cancer risk among women with a family history of breast cancer: effect of women's information sources on their awareness

1 reference

12 December 2020

Descriptive analysis of clinical factors affecting terminally ill cancer patients

1 reference

12 December 2020

Sequential tumor biopsies in early phase clinical trials of anticancer agents for pharmacodynamic evaluation.

1 reference

12 December 2020

Cancer: the road to Amiens

1 reference

12 December 2020

A survey of Internet utilization among patients with cancer

1 reference

12 December 2020

10.1007/S00432-013-1404-6

Identifiers

DOI

1 reference

25 November 2017

1 reference